Solventum Corp(SOLV)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,263 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in SOLV
Events flagged as statistical outliers against SOLV's own multi-year baseline — not fixed dollar thresholds.
- Score shock2026-08-08
SOLV quality score dropped 9 points (56→47) on a new filing
View source filing →
SOLV Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for Solventum Corp (SOLV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SOLV at 55.2/100 on a 32-signal composite quality model, placing it at rank #1,263 of 2,960 stocks — the top half of the AI-ranked universe. SOLV scores in the top quartile across balance sheet strength (85.0), revenue scale (84.4), profitability (81.6). Areas of concern include free cash flow (24.3) and revenue growth (25.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 40.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Solventum Corp reports quarterly revenue of $2.2B, net income of $92.0M, free cash flow of $144.0M. Top institutional holders of SOLV by reported 13-F value include Independent Franchise Partners LLP, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. SOLV trades on the NYSE exchange and files with the SEC under CIK 1964738. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SOLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Solventum Corp directly from SEC EDGAR. Solventum Corp's 13F Pro composite quality score has ranged between 47 and 67 since 2025, currently 55.2 — a declining long-term trajectory across 53 quarterly and live scoring snapshots.
Revenue
Q2 2026
$2.2B
Net Income
Q2 2026
$92.0M
Free Cash Flow
Q2 2026
$144.0M
ROIC
Q2 2026
7.3%
D/E Ratio
Q2 2026
1.06
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+0.9% YoYNet Income
+224.8% YoYOperating Income
+110.5% YoYEPS (Diluted)
+221.7% YoYTotal Assets
-1.1% YoYTotal Debt
-40.1% YoYOp. Cash Flow
-68.9% YoYFree Cash Flow
-101.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $8.32B +0.9% | $8.25B +0.7% | $8.20B +0.8% | $8.13B | — |
| Net Income | $1.56B +224.8% | $479.0M -64.4% | $1.35B +0.2% | $1.34B | — |
| Operating Income | $2.18B +110.5% | $1.04B -38.8% | $1.69B -0.1% | $1.69B | — |
| EPS (Diluted) | $8.88 +221.7% | $2.76 -64.6% | $7.79 +0.1% | $7.78 | — |
| Total Assets | $14.29B -1.1% | $14.46B +3.7% | $13.94B | — | — |
| Total Debt | $5.04B -40.1% | $8.41B | $0.00 | — | — |
| Operating Cash Flow | $369.0M -68.9% | $1.19B -38.1% | $1.92B +14.1% | $1.68B | — |
| Free Cash Flow | $-10.0M -101.2% | $805.0M -50.5% | $1.63B +13.8% | $1.43B | — |
Get alerted when SOLV's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Solventum Corp including:
Top Institutional Holders of SOLV
Independent Franchise Partners LLP
$1.2B16,170,038 shBlackRock, Inc.
$753.1M9,761,863 shVANGUARD CAPITAL MANAGEMENT LLC
$742.6M9,624,829 shTRIAN FUND MANAGEMENT, L.P.
$635.5M8,236,753 shVANGUARD PORTFOLIO MANAGEMENT LLC
$488.3M6,328,641 shDAVIS SELECTED ADVISERS
$486.7M6,307,729 shSTATE STREET CORP
$435.1M5,639,230 shGEODE CAPITAL MANAGEMENT, LLC
$378.3M4,910,624 shBoston Partners
$311.5M4,037,963 shInvesco Ltd.
$255.4M3,309,915 sh
| Fund | Value | Shares |
|---|---|---|
| Independent Franchise Partners LLP | $1.2B | 16,170,038 |
| BlackRock, Inc. | $753.1M | 9,761,863 |
| VANGUARD CAPITAL MANAGEMENT LLC | $742.6M | 9,624,829 |
| TRIAN FUND MANAGEMENT, L.P. | $635.5M | 8,236,753 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $488.3M | 6,328,641 |
| DAVIS SELECTED ADVISERS | $486.7M | 6,307,729 |
| STATE STREET CORP | $435.1M | 5,639,230 |
| GEODE CAPITAL MANAGEMENT, LLC | $378.3M | 4,910,624 |
| Boston Partners | $311.5M | 4,037,963 |
| Invesco Ltd. | $255.4M | 3,309,915 |
Companies Similar to SOLV
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
GE HealthCare Technologies Inc.
Solstice Advanced Materials Inc.
3M CO
Medtronic plc
BOSTON SCIENTIFIC CORP
LABCORP HOLDINGS INC.
STERIS plc
Indivior Pharmaceuticals, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put SOLV on your watchlist
Track score changes the day Solventum Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SOLV a good stock to buy?
13F Pro's AI-powered analysis of Solventum Corp (SOLV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SOLV are available on the SOLV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SOLV is classified as a large company.
Which hedge funds own SOLV?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SOLV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Solventum Corp's investment landscape.